Thyroid hormone analogs for promoting angiogenesis
Details for Australian Patent Application No. 2005284879 (hide)
International Classifications
Event Publications
19 April 2007 PCT application entered the National Phase
PCT publication WO2006/031922 Priority application(s): WO2006/031922
21 October 2010 Alteration of Name
The name of the applicant has been altered to Albany College of Pharmacy and Health Sciences; Ordway Research Institute, Inc.
14 April 2011 Application Accepted
Published as AU-B-2005284879
11 August 2011 Standard Patent Sealed
12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005284885-Ultra-violet inhibition system
2005284875-Table game validation system having a bulk note feeder assembly
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser